mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-07 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
9e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |